These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 2866709)

  • 1. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers.
    Massie BM
    Am J Cardiol; 1985 Dec; 56(16):97H-100H. PubMed ID: 2866709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
    Leon MB; Rosing DR; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris.
    Krikler DM; Harris L; Rowland E
    Am Heart J; 1982 Sep; 104(3):702-8. PubMed ID: 6126115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.
    Strauss WE; Parisi AF
    Ann Intern Med; 1988 Oct; 109(7):570-81. PubMed ID: 2901816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonists in the treatment of arterial hypertension].
    Kuznetsov VN
    Klin Med (Mosk); 1985 Nov; 63(11):9-15. PubMed ID: 2868150
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies of calcium-channel blockers and beta-blockers in essential hypertension: clinical implications.
    Massie BM; Tubau JF; Szlachcic J
    Circulation; 1987 Jun; 75(6 Pt 2):V163-9. PubMed ID: 2882873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for calcium channel antagonist therapy according to the latest large clinical trials].
    Kosicka T; Kara-Perz H; Głuszek J; Perz S
    Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium antagonists in the therapy of hypertension].
    Heidland A; Heidbreder E; Hörl WH; Schäfer RM
    Klin Wochenschr; 1983 Jul; 61(13):633-40. PubMed ID: 6350692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium blockers for heart disease: two approved, more to come.
    Kangilaski J; McBride G
    JAMA; 1982 Apr; 247(14):1911-3, 1917. PubMed ID: 6121064
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension with calcium channel blockers: European data.
    Klein WW
    Am J Med; 1984 Oct; 77(4A):143-6. PubMed ID: 6385698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers as antihypertensive agents.
    Massie BM; Hirsch AT; Inouye IK; Tubau JF
    Am J Med; 1984 Oct; 77(4A):135-42. PubMed ID: 6091447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers. Potential medical benefits and side effects.
    Dustan HP
    Hypertension; 1989 May; 13(5 Suppl):I137-40. PubMed ID: 2490817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of optimal drug therapy for the patient with angina pectoris.
    Shub C; Vlietstra RE; McGoon MD
    Mayo Clin Proc; 1985 Aug; 60(8):539-48. PubMed ID: 2862309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the effect of 3 calcium antagonists in chronic stable angina].
    Román O; Gac JC; Ramírez J; Rebolledo H; Valenzuela MA; Antunez C
    Rev Med Chil; 1988 Jul; 116(7):626-32. PubMed ID: 3076972
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.